Drais in-licenses Diatos' DTS-108

Diatos (Paris, France) granted Drais (Bridgewater, N.J.) exclusive, worldwide rights to develop and commercialize DTS-108 to treat solid tumors. The prodrug of SN38 delivered using Vectocell peptide-b...